Recent News

572 News Items found
Pictured: Stem cell-derived nerve cells exposed to progerin
In the Lab
A team of Memorial Sloan Kettering scientists has come up with an approach to make stem-cell-derived neurons rapidly age in a cell culture dish. The breakthrough could transform research into Parkinson’s and other late-onset diseases.
Cancer research pioneer Janet Rowley
In Memoriam
Memorial Sloan Kettering President and CEO Craig Thompson reflects on the life and career of cancer research pioneer Janet Rowley.
Pictured: Alexander Rudensky
Profile
At Work: Immunologist Alexander Rudensky
Alexander Rudensky’s research focuses on the role of a subset of white blood cells called regulatory T cells, which are believed to suppress the immune system’s ability to fight tumors.
Pictured: Charles L. Sawyers, William Polkinghorn & Simon Powell
In the Lab
Laboratory studies have revealed an explanation for why androgen-deprivation therapy makes radiation therapy more effective in the treatment of high-risk prostate cancer.
In the News
Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.
Pictured: Michael Foley
Announcement
A renowned chemist with 25 years of industry and academic experience, Michael Foley will lead a pioneering collaboration designed to speed the development of new drugs for people with cancer and other diseases.
Pictured: Joan Massagué
Announcement
Internationally recognized cancer biologist Joan Massagué has been named Director of the Sloan Kettering Institute. He was previously Chair of the Cancer Biology and Genetics Program at Memorial Sloan Kettering.
Pictured: Stephen Long & Alexandria Miller
Profile
At Work: Structural Biologist Stephen Long
Stephen Long works to understand how proteins work by determining what they look like in three dimensions.
Pictured: Craig Thompson
Event
Memorial Sloan Kettering’s annual seminar exposes high school students and their teachers to cutting-edge scientific research.
Pictured: Laurie Glimcher, Craig Thompson, Marc Tessier-Lavigne & Tadataka Yamada
Announcement
Memorial Sloan Kettering is joining with two other academic institutions in a pioneering collaboration to speed early-stage drug discoveries into therapies for patients.